公司概覽
業務類別 Biotechnology
業務概覽 Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The companyleverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
公司地址 7495 New Horizon Way, Frederick, MD, USA, 21703
電話號碼 +1 301 348-8698
傳真號碼 +1 617 924-3454
公司網頁 https://www.cartesiantherapeutics.com
員工數量 66
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Carsten Brunn, PhD Chairman of the Board, President and Chief Executive Officer 美元 642.72K 30/10/2025
Dr. Milos Miljkovic, M.D. Chief Medical Officer -- 28/04/2025
Dr. Emily English, PhD Chief Operations Officer, Senior Vice President and Head of Manufacturing -- 28/04/2025
Mr. Blaine Davis Chief Financial Officer and Principal Accounting Officer 美元 462.00K 08/10/2025
Ms. June Ann Seymour Chief Accounting Officer -- 08/10/2025
 
董事會成員
董事會 職務 更新日期
Dr. Carsten Brunn, PhD Chairman of the Board, President and Chief Executive Officer 30/10/2025
Dr. Murat Kalayoglu, M.D.,PhD Independent Director 28/04/2025
Dr. Kemal Malik Director 28/04/2025
Mr. Patrick J. Zenner Lead Independent Director 30/10/2025
Dr. Adrian Ion Bot, M.D.,PhD Director 18/12/2025
Mr. Timothy C. Barabe Independent Director 28/04/2025
Dr. Nishan de Silva, M.B.A.,M.D. Independent Director 28/04/2025
Dr. Michael Singer, M.D.,PhD Independent Director 28/04/2025
Dr. Timothy A. Springer, M.D.,PhD Director 28/04/2025
 
所屬ETF (更新日期: 07/03/2026 04:15)
代號 名稱 佔比% 持有日期
VTWOVanguard Russell 2000 ETF0.19%31/01/2026
IWCiShares Micro-Cap ETF0.11%28/02/2026
IWOiShares Russell 2000 Growth ETF0.06%28/02/2026
VTWVVanguard Russell 2000 Value ETF0.03%31/01/2026
VTWGVanguard Russell 2000 Growth ETF0.004%31/01/2026
UWMProShares Ultra Russell20000.002%27/02/2026
URTYProShares UltraPro Russell20000.002%27/02/2026
VTHRVanguard Russell 3000 ETF0.002%31/01/2026
ITWOProShares Russell 2000 High Income ETF0.002%27/02/2026
GUGGuggenheim Active Allocation Fund0.0001%30/11/2025
HDGProShares Hedge Replication0.00005%27/02/2026
BBCVirtus LifeSci Biotech Clinical Trls ETF<0.000001%16/12/2025
BIBProShares Ultra Nasdaq Biotechnology<0.000001%22/12/2025
IBBiShares Biotechnology ETF<0.000001%19/12/2025
IBBQInvesco Nasdaq Biotechnology ETF<0.000001%22/12/2025
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF<0.000001%21/10/2025
SBIOALPS Medical Breakthroughs ETF<0.000001%20/06/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.